Depression and Treatment: Is It a Symptom or a Side Effect?

This podcast episode is for people who are living with depression or their care partners; or anyone who is interested in learning more about depression. The goal of this episode is to help you talk to and work with your doctor about symptoms of depression and treatment side effects.

You will learn about:

Common symptoms of depression
Types of medicines approved to treat depression and possible side effects that may happen
Talking to your doctor and healthcare team about your symptoms and side effects

SUBSCRIBE FOR FREE: Apple Podcasts | Google Podcasts

Drs Rakesh Jain and Denise Vanacore talk about what you should know about symptoms and treatment side effects while living with depression.

LISTEN FROM YOUR APP: Apple Podcasts | Google Podcasts

Authors and Disclosures

Faculty

Rakesh Jain, MD, MPH

Clinical ProfessorDepartment of PsychiatryTexas Tech Health Sciences CenterSchool of Medicine -- Permian BasinMidland, Texas Rakesh Jain, MD, MPH, has the following relevant financial relationships:Consultant or advisor for: AbbVie; Acadia; Adamas; Alfasigma; Alkermes; Allergan; Axsome; Corium; Cingulate Therapeutics; Eisai; Evidera; Impel; Janssen; Lilly; Lundbeck; Merck; Neos Therapeutics; Neurocrine Biosciences; Osmotica; Otsuka; Pamlab; Pfizer; Sage Therapeutics; Shire; Sunovion; Supernus; Takeda; Teva; Transcend Therapeutics; Usona.Speaker or member of speakers bureau for: AbbVie; Alkermes; Allergan; Axsome; Corium; Eisai; Indivior; Intra-Cellular Therapies; Ironshore Pharmaceuticals; Janssen; Lilly; Lundbeck; Merck; Neos Therapeutics; Neurocrine; Otsuka; Pamlab; Pfizer; Shire; Sunovion; Takeda; Teva; Tris Pharmaceuticals.

Denise Vanacore Chase, PhD, FNP-BC, PMHNP-BC

Associate Dean and Professor of NursingEastern UniversitySt. Davids, Pennsylvania Denise Vanacore Chase, PhD, FNP-BC, PMHNP-BC, has no relevant financial relationships.

Editor

Anita A. Galdieri, PharmD, RPh

Associate Director, Content Development. Medscape, LLC. Anita A. Galdieri, PharmD, RPh, has no relevant financial relationships.